Augmedix, Inc. — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9eb3945d-6d41-47da-b18e-c3113107c6fc/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $44.9M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-013117 |
| FY 2022 | $30.9M | 2022-01-01 – 2022-12-31 | evidence 0001628280-24-013117 |
| FY 2021 | $22.2M | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-016250 |
| FY 2020 | $16.5M | 2020-01-01 – 2020-12-31 | evidence 0001213900-22-016250 |
| FY 2019 | $14.1M | 2019-01-01 – 2019-12-31 | evidence 0001213900-21-018844 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).